| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.31 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |